capecitabine
CHEBI:CHEBI_31348
Definition
A carbamate ester that is cytidine in which the hydrogen at position 5 is replaced by fluorine and in which the amino group attached to position 4 is converted into its N-(penyloxy)carbonyl derivative. Capecitabine is a antineoplastic agent used in the treatment of cancers.
Chemical Information
- Molecular Formula
- C15H22FN3O6
- Molecular Mass
- 359.35010
- Charge
- 0
- SMILES
- CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
- InChI
- InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
- InChIKey
- GAGWJHPBXLXJQN-UORFTKCHSA-N
Alternative Names
- (1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
- 5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
- Capecitabin
- capecitabina
- capecitabine
- capecitabinum
- Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
- pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
- Xeloda
Drug Classification
-
carbamate esterView Class →
CHEBI:23003
-
organofluorine compoundView Class →
CHEBI:37143
-
cytidinesView Class →
CHEBI:23524
-
t179001
-
t180053
-
t180129
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 194000
- oboInOwl#hasDbXref
- Wikipedia:Capecitabine
- core#notation
- CHEBI:31348
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- route
- ORAL
- package_ndc
- 72606-555-01
- spl_id
- 680dac89-d210-4eb8-a955-bf40e652c546
- package_marketing_start_date
- 20-APR-11
- package_description
- 120 TABLET, FILM COATED in 1 BOTTLE (72606-555-01)
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- dosage_form
- CRYSTAL
- marketing_start_date
- 20070829
- labeler_name
- Roche Carolina Inc.
- application_number
- ANDA200483
- product_ndc
- 16729-073
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 194000
- generic_name
- CAPECITABINE
- brand_name
- Capecitabine 500mg
- brand_name_base
- Capecitabine 500mg
- oboInOwl#hasDbXref
- Wikipedia:Capecitabine
- oboInOwl#id
- CHEBI:31348
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50266
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- core#notation
- CHEBI:31348
- pharm_class_moa
- Nucleic Acid Synthesis Inhibitors [MoA]
- pharm_class
- Nucleoside Metabolic Inhibitor [EPC]
- pharm_class_epc
- Nucleoside Metabolic Inhibitor [EPC]
- upc
- 0369539020997
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rxcui
- 213293
- active_ingredient_strength
- 25 kg/25kg
- manufacturer_name
- Pilnova Pharma Inc
- active_ingredient_name
- CAPECITABINE
- unii
- 6804DJ8Z9U
- spl_set_id
- 56ada01c-b033-4108-85e5-ebe5f2bd9ee9
- nui
- N0000175595
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6703
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect16575
- owl#annotatedSource
- t180257
- owl#someValuesFrom
- t720316